These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

252 related items for PubMed ID: 1902643

  • 21. Factor VIII:C inhibitor associated with monoclonal-antibody purified FVIII concentrate.
    Kessler CM, Sachse K.
    Lancet; 1990 Jun 09; 335(8702):1403. PubMed ID: 1971683
    [No Abstract] [Full Text] [Related]

  • 22. Inhibitor antibody development and T cell response to human factor VIII in murine hemophilia A.
    Qian J, Borovok M, Bi L, Kazazian HH, Hoyer LW.
    Thromb Haemost; 1999 Feb 09; 81(2):240-4. PubMed ID: 10063999
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Immunetolerance as treatment of alloantibodies to factor VIII in hemophilia. The International Registry of Immunetolerance Protocols.
    Mariani G, Scheibel E, Nogao T, Kasper CK, Ewing NP, Mauser-Bunschoten E, Ghirardini A, Bellocco R, Brackman HH.
    Semin Hematol; 1994 Apr 09; 31(2 Suppl 4):62-4. PubMed ID: 7939781
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Factor VIII inhibitors.
    Gilles JG, Jacquemin MG, Saint-Remy JM.
    Thromb Haemost; 1997 Jul 09; 78(1):641-6. PubMed ID: 9198231
    [No Abstract] [Full Text] [Related]

  • 35. The use of agents that by-pass factor VIII inhibitors in patients with haemophilia.
    Roberts HR.
    Vox Sang; 1999 Jul 09; 77 Suppl 1():38-41. PubMed ID: 10529686
    [No Abstract] [Full Text] [Related]

  • 36. Prevention of inhibitor development in hemophilia A in 2016. A glimpse into the future?
    Franchini M, Lippi G.
    Thromb Res; 2016 Dec 09; 148():96-100. PubMed ID: 27816852
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. [Improvement in anti-hemophilic preparations and its problems. 3. Treatment of hemophilia patients with inhibitors; induction of immune tolerance by a low or intermediate dose regimen].
    Iizuka A.
    Rinsho Ketsueki; 1988 May 09; 29(5):640-8. PubMed ID: 3145995
    [No Abstract] [Full Text] [Related]

  • 39. Management of factor VIII inhibitors.
    Acharya SS, DiMichele DM.
    Best Pract Res Clin Haematol; 2006 May 09; 19(1):51-66. PubMed ID: 16377541
    [Abstract] [Full Text] [Related]

  • 40. Pattern of factor VIII inhibitors in patients with hemophilia A in the north east of Iran.
    Modaresi AR, Torghabeh HM, Pourfathollah AA, Shooshtari MM, Yazdi ZR.
    Hematology; 2006 Jun 09; 11(3):215-7. PubMed ID: 17325965
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 13.